Prefusion piv f immunogens and their use
US-2026022145-A1 · Jan 22, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ou Li patents
Ou Li is listed as an inventor on 33 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ou Li |
| Total patents | 33 |
| First publication | Jul 20, 2017 |
| Latest publication | Jan 22, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Prefusion rsv f proteins and their use
US-2025388627-A1 · Dec 25, 2025 · US
HIV-1 ENV fusion peptide immunogens and their use
US-12458691-B2 · Nov 4, 2025 · US
Prefusion PIV F immunogens and their use
US-12435113-B2 · Oct 7, 2025 · US
Adaptive system probe action to minimize input/output dirty data transfers
US-12417179-B2 · Sep 16, 2025 · US
Adaptive System Probe Action to Minimize Input/Output Dirty Data Transfers
US-2025217292-A1 · Jul 3, 2025 · US
Prefusion RSV F proteins and their use
US-12275758-B2 · Apr 15, 2025 · US
Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteins
US-2024299510-A1 · Sep 12, 2024 · US
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
US-12053519-B2 · Aug 6, 2024 · US
Enhanced low-priority arbitration
US-12045182-B1 · Jul 23, 2024 · US
Recent patents
Latest publications not already listed above.
Prefusion-stabilized lassa virus glycoprotein complex and its use
US-2024228549-A1 · Jul 11, 2024 · US
Prefusion piv f immunogens and their use
US-2024101609-A1 · Mar 28, 2024 · US
Prefusion RSV F proteins and their use
US-11878998-B2 · Jan 23, 2024 · US
Crispr-mediated human genome editing with vectors
US-2023416776-A1 · Dec 28, 2023 · US
Prefusion PIV F immunogens and their use
US-11845778-B2 · Dec 19, 2023 · US
Stabilized norovirus virus-like particles as vaccine immunogens
US-2023381293-A1 · Nov 30, 2023 · US
Modified hexosaminidase and uses thereof
US-2023374483-A1 · Nov 23, 2023 · US
Hiv-1 env fusion peptide immunogens and their use
US-2023338507-A1 · Oct 26, 2023 · US
Methods and compositions for the treatment of neurologic disease
US-2023330195-A1 · Oct 19, 2023 · US
Crispr-mediated genome editing with vectors
US-2023201373-A1 · Jun 29, 2023 · US
Enhanced low-priority arbitration
US-11675718-B2 · Jun 13, 2023 · US
Recombinant human metapneumovirus f proteins and their use
US-2023174587-A1 · Jun 8, 2023 · US
HIV-1 Env fusion peptide immunogens and their use
US-11602559-B2 · Mar 14, 2023 · US
Enhanced Low-Priority Arbitration
US-2022309013-A1 · Sep 29, 2022 · US
Prefusion rsv f proteins and their use
US-2022064222-A1 · Mar 3, 2022 · US
Prefusion piv f immunogens and their use
US-2022024987-A1 · Jan 27, 2022 · US
Hiv-1 env fusion peptide nanoparticle carrier conjugates and their use
US-2021353740-A1 · Nov 18, 2021 · US
Substitutions-modified prefusion RSV F proteins and their use
US-11174292-B2 · Nov 16, 2021 · US
Prefusion PIV F immunogens and their use
US-11078239-B2 · Aug 3, 2021 · US
Hiv-1 env fusion peptide immunogens and their use
US-2020230229-A1 · Jul 23, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Us Health | 15 |
| The Us Secretary Department Of Health And Human Servic | 7 |
| Inst Res Biomedicine | 6 |
| Univ Minnesota | 5 |
| Advanced Micro Devices Inc | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K14/005 | 22 |
| A61K39/12 | 22 |
| A61P31/14 | 15 |
| C07K2319/50 | 14 |
| C12N7/00 | 13 |